You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

human beta-defensin

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

Recruiting
  • HIV Infection
  • +10 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • La Jolla, California
  • +3 more
Dec 7, 2022

Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)

Not yet recruiting
  • Beta-Thalassemia
  • +6 more
  • CTX001
  • (no location specified)
Jul 26, 2022

Asthma Trial in London, Manchester (Human beta common receptor antagonist mAb, Placebo)

Recruiting
  • Asthma
  • Human beta common receptor antagonist monoclonal antibody
  • Placebo
  • Berlin, Germany
  • +2 more
Dec 21, 2022

Healthy Subject, Pancreatic Carcinoma Trial in Palo Alto (diagnostic test, other, drug)

Active, not recruiting
  • Healthy Subject
  • Pancreatic Carcinoma
  • Computed Tomography
  • +3 more
  • Palo Alto, California
    Stanford University, School of Medicine
Apr 8, 2022

Transfusion Dependent Beta-Thalassaemia Trial in Guangzhou, Shenzhen, Tianjin (ET-01)

Active, not recruiting
  • Transfusion Dependent Beta-Thalassaemia
  • ET-01
  • Guangzhou, Guangdong, China
  • +3 more
May 9, 2022

Fabry Disease Trial in Worldwide (PRX-102 (pegunigalsidase alfa), agalsidase beta)

Completed
  • Fabry Disease
  • PRX-102 (pegunigalsidase alfa)
  • agalsidase beta
  • Birmingham, Alabama
  • +28 more
Oct 12, 2022

Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)

Active, not recruiting
  • Beta-Thalassemia
  • +4 more
  • CTX001
  • Stanford, California
  • +11 more
Nov 30, 2022

Type 2 Diabetes Trial (Clenbuterol Hydrochloride, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • Clenbuterol Hydrochloride
  • Placebo
  • (no location specified)
Jun 2, 2021

Mantle Cell Lymphoma Trial in United States (Acalabrutinib, Bortezomib, Cyclophosphamide)

Recruiting
  • Mantle Cell Lymphoma
  • New Orleans, Louisiana
  • +5 more
Dec 13, 2022

Advanced Malignant Solid Tumor, Hepatocellular Carcinoma Trial in Scottsdale (Laboratory Biomarker Analysis, Pharmacological

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • Hepatocellular Carcinoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Oct 6, 2021

Beta-Thalassemia Trial in Worldwide (LJPC-401)

Terminated
  • Beta-Thalassemia
  • Oakland, California
  • +21 more
Jul 28, 2021

Ketosis Trial in Guelph (D-beta-hydroxybutyrate, Placebo)

Active, not recruiting
  • Ketosis
  • D-beta-hydroxybutyrate
  • Placebo
  • Guelph, Ontario, Canada
    University of Guelph - Human Cardiovascular Physiology Laborator
Jun 13, 2022

Infant Development Trial in Jinhua (BLM ORGANIC GOLD+, BLM ORGANIC, Breast milk)

Not yet recruiting
  • Infant Development
  • BLM ORGANIC GOLD+
  • +2 more
  • Jinhua, Zhejiang, China
    Qiu Bin Community Hospital
Jan 12, 2023

Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in United States (drug, other, biological)

Recruiting
  • Hematologic and Lymphocytic Disorder
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Placebo Administration
  • +3 more
  • Duarte, California
  • +3 more
Dec 14, 2022

Premature Infant Trial in France (HMO supplement, Placebo comparator)

Active, not recruiting
  • Premature Infant
  • HMO supplement
  • Placebo comparator
  • Bordeaux, France
  • +6 more
Feb 16, 2022

Crohn Disease Trial in Bamberg (lifestyle-modification, waiting control group)

Active, not recruiting
  • Crohn Disease
  • lifestyle-modification
  • waiting control group
  • Bamberg, Bayern, Germany
    Sozialstiftung Bamberg, Klinik für Intergrative Medizin
Feb 3, 2022

Obesity Trial in Davis (Diet and Exercise)

Completed
  • Obesity
  • Diet and Exercise
  • Davis, California
    Western Human Nutrition Research Center
Jul 2, 2021

Immunity, Vaccine Reaction, Influenza Trial in Barcelona (ABBC1 Immunoessential, Placebo)

Completed
  • Immunity
  • +5 more
  • ABBC1 Immunoessential
  • Placebo
  • Barcelona, Spain
    Hospital Mare de Déu de la Mercè - Germanes Hospitalàries
Jul 19, 2022

Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

Recruiting
  • Myelodysplastic Syndrome
  • +16 more
  • Computed Tomography
  • +6 more
  • Scottsdale, Arizona
  • +2 more
Feb 3, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Neuroblastoma Trial in Madison, Southampton, London (Nivolumab, Ch14.18/CHO)

Recruiting
  • Neuroblastoma
  • Madison, Wisconsin
  • +2 more
Mar 28, 2022

Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia Trial in

Terminated
Has Results
  • Philadelphia Chromosome Negative
  • +2 more
  • Blinatumomab
  • +11 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 3, 2022

Non-Malignant Tumor Trial in Seattle (biological, drug, radiation, procedure)

Recruiting
  • Non-Malignant Neoplasm
  • Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 29, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Jan 12, 2023

Infertility Trial (MK-8962, recFSH, Ganirelix)

Withdrawn
  • Infertility
  • (no location specified)
Feb 1, 2022